Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience.
Inuk ZandvakiliCaitlin B ConboyAyed O AyedElizabeth J Cathcart-RakeAyalew TefferiPublished in: American journal of hematology (2018)
Keyphrases